BDX · Becton Dickinson & Co · Insider Trading

Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards

Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards

Award terms reflect the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.

The stock appreciation rights vested in four annual installments beginning November 26, 2018.

Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP").

Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.

The securities convert to common stock on a one-for-one basis.

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Includes rights acquired through dividend investment since the last report filed by the reporting person.

The securities convert to common stock on a one-for-one basis.

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Includes rights acquired through dividend investment since the last report filed by the reporting person.

Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $145.21 through $147.49. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Award terms reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.

The stock appreciation rights vested in four annual installments beginning November 26, 2017.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

The securities convert to common stock on a one-for-one basis.

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person.

The securities convert to common stock on a one-for-one basis.

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Includes rights acquired through dividend investment since the last report filed by the reporting person.

Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 7, 2025.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

The securities convert to common stock on a one-for-one basis.

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

The securities convert to common stock on a one-for-one basis.

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

The securities convert to common stock on a one-for-one basis.

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Includes units acquired through dividend investment since the last report filed by the reporting person.

Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.